PharmaShots | Incisive News in 3 Shots

Subscribe Now

Pipeline Portfolio

Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

Silence Therapeutics Highlights its R&D Pipeline and Initiates Dose Escalation Studies for SLN360

September 8, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us